T. Sarashina, R. Kobayashi, Makoto Yoshida
Nov 1, 2014
Citations
2
Influential Citations
16
Citations
Quality indicators
Journal
Pediatric Blood & Cancer
Abstract
Febrile neutropenia (FN) is a common and serious complication of cancer chemotherapy associated with significant morbidity and mortality. Cefozopran (CZOP) is a potential candidate for empirical monotherapy in FN. However, studies on the use of CZOP as empirical treatment for pediatric patients with FN are quite limited. The purpose of this study was to compare the efficacy and safety of CZOP with cefepime (CFPM) empirical monotherapy in pediatric cancer patients with FN.